FREE Webinar Digital/Virtual EMG-Biofeedback - an effective, non-invasive treatment for Migraine EMG Biofeedback (EMG-BF) is an FDA approved, clinically studied, non-invasive and effective modality to treat migraine and tension type headache. American Migraine Foundation claims that EMG-BF is as effective as many migraine medications but without the serious side effects. Due to technology factors and scarce clinical skills, currently EMG-BF is only available in limited academic hospitals. JOGO is a modern, digital EMG-BF system that gives the flexibility for patients to receive the treatment virtually from anywhere. We will be sharing the results of a latest JOGO clinical trial conducted at Brigham and Women's Hospital, the teaching Hospital of Harvard Medical School. Speakers: Carolyn A. Bernstein, MD, FAHS, Lavine Family Distinguished Chair in Neurology, Brigham and Women's Hospital Harvard Medical School, USA Asimina Lazaridou, PhD Research Scientist Department of Anesthesiology Brigham and Women's Hospital Harvard Medical School, USA Myrella Paschali, MD Psychiatrist Department of Psychiatry and Psychotherapy Heinrich Heine University Düsseldorf, Germany
This content isn’t available here
Access this content and more in the LinkedIn app